Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1992 3
1993 1
1996 3
1997 1
1999 1
2002 2
2003 1
2005 3
2006 1
2007 4
2008 2
2009 4
2010 4
2011 3
2012 4
2013 5
2014 8
2015 4
2016 9
2017 8
2018 5
2019 5
2021 3
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Clinical Trial.
Ezetimibe and Insulin Resistance.
Popovic DS, Papachristou S, Stokic E, Papanas N. Popovic DS, et al. Among authors: stokic e. Curr Vasc Pharmacol. 2022;20(4):315-317. doi: 10.2174/1570161120666220301140528. Curr Vasc Pharmacol. 2022. PMID: 35232351 No abstract available.
PCSK9 and Hypercholesterolemia: Therapeutic Approach.
Obradovic M, Zaric B, Sudar-Milovanovic E, Ilincic B, Stokic E, Perovic M, Isenovic ER. Obradovic M, et al. Among authors: stokic e. Curr Drug Targets. 2018;19(9):1058-1067. doi: 10.2174/1389450119666171205101401. Curr Drug Targets. 2018. PMID: 29210646 Review.
Peroxisome proliferator-activated receptors and atherosclerosis.
Soskić SS, Dobutović BD, Sudar EM, Obradović MM, Nikolić DM, Zarić BL, Stojanović SD, Stokić EJ, Mikhailidis DP, Isenović ER. Soskić SS, et al. Among authors: stokic ej. Angiology. 2011 Oct;62(7):523-34. doi: 10.1177/0003319711401012. Epub 2011 Apr 5. Angiology. 2011. PMID: 21467121 Review.
The relationship between vitamin D and obesity.
Soskić S, Stokić E, Isenović ER. Soskić S, et al. Among authors: stokic e. Curr Med Res Opin. 2014 Jun;30(6):1197-9. doi: 10.1185/03007995.2014.900004. Epub 2014 Mar 18. Curr Med Res Opin. 2014. PMID: 24640937
Methods for algorithmic diagnosis of metabolic syndrome.
Vrbaški D, Vrbaški M, Kupusinac A, Ivanović D, Stokić E, Ivetić D, Doroslovački K. Vrbaški D, et al. Among authors: stokic e. Artif Intell Med. 2019 Nov;101:101708. doi: 10.1016/j.artmed.2019.101708. Epub 2019 Oct 15. Artif Intell Med. 2019. PMID: 31813488
83 results